SCHEMBL6492166

SCHEMBL6492166

CCOC(=O)CCCOc1cc(C)c2nc(C)n(Cc3ccc(-c4ccccc4)cc3Cl)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.43
PLA2G2A P14555 3/20 0.42
FAAH O00519 4/20 0.42
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYSLTR2 Q9NS75 3/20 0.40
CYSLTR1 Q9Y271 3/20 0.40
PIN1 Q13526 1/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
P2RY12 Q9H244 1/20 0.38
MCL1 Q07820 2/20 0.38
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DHFR P00374 2/20 0.36
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489813 0.91 MCL1 (0.43) PLA2G2APIN1MCL1
SCHEMBL6498663 0.90 GAA (0.39) GAAPLA2G2AFAAHKDM4EALDH1A1
SCHEMBL6489154 0.90 ALDH1A1 (0.47) GAAPLA2G2AFAAHKDM4EALDH1A1
SCHEMBL6498255 0.89 FAAH (0.41) GAAPLA2G2AFAAHCYSLTR2CYSLTR1
SCHEMBL6502915 0.89 SMN1; SMN2 (0.44) PLA2G2AKDM4EALDH1A1MAPTHPGD
SCHEMBL6488241 0.88 MCL1 (0.43) PLA2G2AFAAHKDM4EALDH1A1MAPT
SCHEMBL6488150 0.88 PLA2G2A (0.42) GAAPLA2G2AFAAHKDM4EALDH1A1
SCHEMBL6499832 0.87 PLA2G2A (0.42) PLA2G2AKDM4EALDH1A1MAPTHPGD
SCHEMBL6491512 0.87 MCL1 (0.41) PLA2G2AALDH1A1MAPTHSD17B10CYSLTR2
SCHEMBL6488675 0.87 PLA2G2A (0.41) GAAPLA2G2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD GAA 22/4885PLA2G2A 4801/4885FAAH 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.